| Mary Martha Dowell, CRNA | |
|
4305 New Shepherdsville Rd, Bardstown, KY 40004-9019 | |
| (502) 350-5032 | |
| (502) 350-5022 |
| Full Name | Mary Martha Dowell |
|---|---|
| Gender | Female |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 33 Years |
| Location | 4305 New Shepherdsville Rd, Bardstown, Kentucky |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1346208246 | NPI | - | NPPES |
| 000000558039 | Other | ANTHEM | |
| 2585920 | Medicaid | OH | |
| 50053844 | Other | KY | PASSPORT-SME |
| 000000491683 | Other | KY | BCBS PROVIDER NUMBER |
| 74016627 | Medicaid | KY | |
| 200896870 | Medicaid | IN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | 042295 (Kentucky) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Baptist Health Louisville | Louisville, KY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| One Anesthesia Pllc | 7113816174 | 80 |
News Archive
"Our members agree with the CPSC on the importance of educating consumers about proper, safe babywearing techniques. BCIA is currently developing a babywearing safety education program with Health Canada and we hope to do the same with CPSC."
Regeneron Pharmaceuticals, Inc. and Sanofi today announced that the Phase 3 ODYSSEY JAPAN trial of the investigational therapy Praluent® (alirocumab) Injection met its primary endpoint.
Over the last six years a group of Estonian geneticists led by Associate Professor Agne Velthut-Meikas and a PhD student Ilmatar Rooda from TalTech Department of Chemistry and Biotechnology have studied genes previously associated primarily with female hormone synthesis and ovarian follicle development.
Agilent Technologies Inc. today announced it has purchased the MassCode Tag technology from Eurofins MWG Operon, a division of Eurofins. The purchase includes the MassCode trademarks and intellectual property, including four families of patents.
Eight years ago, results from a landmark cancer prevention trial run by SWOG showed that a daily dose of vitamin E and selenium did not prevent prostate cancer.
› Verified 3 days ago
| Entity Name | Community Anesthesia Of The Bluegrass, Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1477570216 PECOS PAC ID: 4880598788 Enrollment ID: O20031121000759 |
News Archive
"Our members agree with the CPSC on the importance of educating consumers about proper, safe babywearing techniques. BCIA is currently developing a babywearing safety education program with Health Canada and we hope to do the same with CPSC."
Regeneron Pharmaceuticals, Inc. and Sanofi today announced that the Phase 3 ODYSSEY JAPAN trial of the investigational therapy Praluent® (alirocumab) Injection met its primary endpoint.
Over the last six years a group of Estonian geneticists led by Associate Professor Agne Velthut-Meikas and a PhD student Ilmatar Rooda from TalTech Department of Chemistry and Biotechnology have studied genes previously associated primarily with female hormone synthesis and ovarian follicle development.
Agilent Technologies Inc. today announced it has purchased the MassCode Tag technology from Eurofins MWG Operon, a division of Eurofins. The purchase includes the MassCode trademarks and intellectual property, including four families of patents.
Eight years ago, results from a landmark cancer prevention trial run by SWOG showed that a daily dose of vitamin E and selenium did not prevent prostate cancer.
› Verified 3 days ago
| Entity Name | One Anesthesia Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1174513246 PECOS PAC ID: 7113816174 Enrollment ID: O20040315001249 |
News Archive
"Our members agree with the CPSC on the importance of educating consumers about proper, safe babywearing techniques. BCIA is currently developing a babywearing safety education program with Health Canada and we hope to do the same with CPSC."
Regeneron Pharmaceuticals, Inc. and Sanofi today announced that the Phase 3 ODYSSEY JAPAN trial of the investigational therapy Praluent® (alirocumab) Injection met its primary endpoint.
Over the last six years a group of Estonian geneticists led by Associate Professor Agne Velthut-Meikas and a PhD student Ilmatar Rooda from TalTech Department of Chemistry and Biotechnology have studied genes previously associated primarily with female hormone synthesis and ovarian follicle development.
Agilent Technologies Inc. today announced it has purchased the MassCode Tag technology from Eurofins MWG Operon, a division of Eurofins. The purchase includes the MassCode trademarks and intellectual property, including four families of patents.
Eight years ago, results from a landmark cancer prevention trial run by SWOG showed that a daily dose of vitamin E and selenium did not prevent prostate cancer.
› Verified 3 days ago
| Entity Name | T J Samson Community Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1477609865 PECOS PAC ID: 0648182600 Enrollment ID: O20040318001777 |
News Archive
"Our members agree with the CPSC on the importance of educating consumers about proper, safe babywearing techniques. BCIA is currently developing a babywearing safety education program with Health Canada and we hope to do the same with CPSC."
Regeneron Pharmaceuticals, Inc. and Sanofi today announced that the Phase 3 ODYSSEY JAPAN trial of the investigational therapy Praluent® (alirocumab) Injection met its primary endpoint.
Over the last six years a group of Estonian geneticists led by Associate Professor Agne Velthut-Meikas and a PhD student Ilmatar Rooda from TalTech Department of Chemistry and Biotechnology have studied genes previously associated primarily with female hormone synthesis and ovarian follicle development.
Agilent Technologies Inc. today announced it has purchased the MassCode Tag technology from Eurofins MWG Operon, a division of Eurofins. The purchase includes the MassCode trademarks and intellectual property, including four families of patents.
Eight years ago, results from a landmark cancer prevention trial run by SWOG showed that a daily dose of vitamin E and selenium did not prevent prostate cancer.
› Verified 3 days ago
| Entity Name | Purchase Anesthesia, Psc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1215987953 PECOS PAC ID: 1951357847 Enrollment ID: O20050323001200 |
News Archive
"Our members agree with the CPSC on the importance of educating consumers about proper, safe babywearing techniques. BCIA is currently developing a babywearing safety education program with Health Canada and we hope to do the same with CPSC."
Regeneron Pharmaceuticals, Inc. and Sanofi today announced that the Phase 3 ODYSSEY JAPAN trial of the investigational therapy Praluent® (alirocumab) Injection met its primary endpoint.
Over the last six years a group of Estonian geneticists led by Associate Professor Agne Velthut-Meikas and a PhD student Ilmatar Rooda from TalTech Department of Chemistry and Biotechnology have studied genes previously associated primarily with female hormone synthesis and ovarian follicle development.
Agilent Technologies Inc. today announced it has purchased the MassCode Tag technology from Eurofins MWG Operon, a division of Eurofins. The purchase includes the MassCode trademarks and intellectual property, including four families of patents.
Eight years ago, results from a landmark cancer prevention trial run by SWOG showed that a daily dose of vitamin E and selenium did not prevent prostate cancer.
› Verified 3 days ago
| Entity Name | Professional Anesthesia Services Of Kentucky Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1992212807 PECOS PAC ID: 0244590305 Enrollment ID: O20180209000936 |
News Archive
"Our members agree with the CPSC on the importance of educating consumers about proper, safe babywearing techniques. BCIA is currently developing a babywearing safety education program with Health Canada and we hope to do the same with CPSC."
Regeneron Pharmaceuticals, Inc. and Sanofi today announced that the Phase 3 ODYSSEY JAPAN trial of the investigational therapy Praluent® (alirocumab) Injection met its primary endpoint.
Over the last six years a group of Estonian geneticists led by Associate Professor Agne Velthut-Meikas and a PhD student Ilmatar Rooda from TalTech Department of Chemistry and Biotechnology have studied genes previously associated primarily with female hormone synthesis and ovarian follicle development.
Agilent Technologies Inc. today announced it has purchased the MassCode Tag technology from Eurofins MWG Operon, a division of Eurofins. The purchase includes the MassCode trademarks and intellectual property, including four families of patents.
Eight years ago, results from a landmark cancer prevention trial run by SWOG showed that a daily dose of vitamin E and selenium did not prevent prostate cancer.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mary Martha Dowell, CRNA Po Box 936, London, KY 40743-0936 Ph: (502) 350-5032 | Mary Martha Dowell, CRNA 4305 New Shepherdsville Rd, Bardstown, KY 40004-9019 Ph: (502) 350-5032 |
News Archive
"Our members agree with the CPSC on the importance of educating consumers about proper, safe babywearing techniques. BCIA is currently developing a babywearing safety education program with Health Canada and we hope to do the same with CPSC."
Regeneron Pharmaceuticals, Inc. and Sanofi today announced that the Phase 3 ODYSSEY JAPAN trial of the investigational therapy Praluent® (alirocumab) Injection met its primary endpoint.
Over the last six years a group of Estonian geneticists led by Associate Professor Agne Velthut-Meikas and a PhD student Ilmatar Rooda from TalTech Department of Chemistry and Biotechnology have studied genes previously associated primarily with female hormone synthesis and ovarian follicle development.
Agilent Technologies Inc. today announced it has purchased the MassCode Tag technology from Eurofins MWG Operon, a division of Eurofins. The purchase includes the MassCode trademarks and intellectual property, including four families of patents.
Eight years ago, results from a landmark cancer prevention trial run by SWOG showed that a daily dose of vitamin E and selenium did not prevent prostate cancer.
› Verified 3 days ago
Price Richardson, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 4305 New Shepherdsville Rd, Bardstown, KY 40004 Phone: 502-350-5022 | |
Scott Kendall Ohler, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 4305 New Shepherdsville Rd, Anesthesia Department, Bardstown, KY 40004 Phone: 502-350-5032 Fax: 502-350-5022 | |
Roger K Colbert, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 4305 New Shepherdsville Rd, Bardstown, KY 40004 Phone: 502-350-5000 | |
Alan Todd Dossett, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 4305 New Shepherdsville Rd, Bardstown, KY 40004 Phone: 502-350-5032 Fax: 502-350-5022 | |
David S Ellison, CRNA Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 4305 New Shepherdsville Rd, Anesthesia Department, Bardstown, KY 40004 Phone: 502-350-5032 Fax: 502-350-5022 | |
David Wayne Kendrick, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 4305 New Shepherdsville Rd, Anesthesia Department, Bardstown, KY 40004 Phone: 502-350-5032 Fax: 502-350-5022 |